MEDICEN
Are you seeking to develop your R&D skills, enhance your innovation potential and increase your business opportunities ? Check how Medicen Paris Region can help you.
Ms Béatrice Falise-Mirat
CEOMedissimo
Your innovative solution
imedipac is a connceted, rec hageable, pillbox for better treatment adhrence
imedipac's main objective is to increase treatment adherence and measure it
Target market segmentsPatients at home/patients in nursing homes
Well designed connected pillbox/reliability/total traceability/very good knowledge of our market in France
Caroline Blochet
PresidenteMedMira
- 3-step procedure
- Instant results
- Whole blood, serum or plasma specimens
- Up to 24 month shelf-life at 2 – 30° C
- Compact, single-use, 1.28 oz. package
- No refrigeration required
- Built-in procedural and reagent control line
- Standardized procedure across all products
Dr Kevin Jones
Head of CommercializationMemorial Sloan-Kettering Cancer Center
http://www.linkedin.com/pub/hayden-y-t-huang/22/227/913
Memorial Sloan-Kettering Cancer Center
Memorial Sloan Kettering Cancer Center — the world’s oldest and largest private cancer center — has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 45 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.
The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world.
Learn more about Memorial Sloan Kettering.
Mercadyne Investments LLC
Mercadyne Advisors LLC advises private and public companies regarding capital strategy, business strategy, board governance, and restructuring.
Mercadyne enables public companies to maximize shareholder value by positioning the company’s capitalization, Board and enterprise such that Wall Street will reward them for their business.
Mercadyne also provides private companies seeking capital and liquidity an alternative financing path to the conventional, strict venture capital-to-large IPO process. We provide these emerging growth companies with an alternative public offering (APO) or direct public offering (DPO), structure via a public vehicle or small IPO (SIPO) strategy.